Figure 3 - Change in growth velocity during the first 4 years of treatment in patients with IGF1RM (closed circles) and SGA controls (open circle)

IGF1RM carriers showed less height increment than SGA controls within the first year of GH treatment, although this difference became significantly smaller in the following 3 years.